$ILMN Breaks $220 After Q2 Beat and Guidance Raise

$Illumina(ILMN)$

$Illumina(ILMN) +2.89% Surges to 52-Week High, Clinical Sequencing Momentum Breaks $220 Resistance, $230 Target in Sight

Latest Close Data ILMN closed at $219.40 (+2.89%) on Aug 24, touching a fresh 52-week high of $220.43. After-hours strength at $219.11 confirms persistent bid. The stock now sits just 0.5% below that high, with YTD range of $88.00–$220.43.

Core Market Drivers RBC Capital's note that competitive fears are fading in clinical sequencing continues to fuel accumulation. Q2 beat (EPS $1.31 vs $1.23 est.; revenue $11.59B vs $11.30B est.) and raised FY guidance of $4.52–$4.62B keep fundamentals strong. Capital flow turned sharply positive with 5-day net inflow of $3,267.79M.

Technical Analysis Volume of 1.92M shares (VR 1.12) supports the breakout. MACD histogram flipped positive at +1.07 and expanded to +3.21, while DIF (5.25) has crossed above DEA (3.64) — a confirmed bullish crossover. RSI(6) at 81.0 and RSI(12) at 71.1 indicate overbought conditions, but KDJ J-value of 108.4 shows momentum still accelerating. Watch for short-term consolidation before continuation.

Key Price Levels

• Primary Support: $213.24 (prior close / breakout retest zone)

• Immediate Pivot: $219.76 (Aug 21 resistance, now flipped to support)

• Strong Resistance: $220.43 (52-week high) → $230.00 (RBC target)

Valuation Perspective Forward PE of 41.0 is below the historical average of 65.1 and near the +1 Std.Dev level of 128.3, suggesting reasonable valuation relative to growth. P/S TTM of 7.37 and P/B of 11.67 reflect premium quality pricing, justified by 32.3% ROE.

Analyst Targets 19 analysts cover ILMN: 5 Strong Buy, 6 Buy, 8 Hold, 2 Underperform, 1 Sell. Average target $193.95 (below current price), but RBC's $230 high target aligns with the bullish technical breakout.

Weekly Outlook Expect a $213–$230 consolidation range. A daily close above $220.43 opens the path to $230; failure to hold $213.24 could trigger profit-taking toward $208.50 (today's low). Momentum favors continuation, but RSI overbought suggests a brief pause is healthy.

⚠️ Risk Disclaimer: This analysis is for informational purposes only and does not constitute investment advice. Past performance does not guarantee future results. Always conduct your own research before trading.

$Illumina(ILMN) Options Strategy: Bull Call Spread

• Underlying: ILMN (Illumina)

• View: Cautiously bullish; breakout above $220 resistance, targeting $230

• Strategy Type: Debit spread / directional long with defined risk

• Option Contract Portfolio:

  • Buy 1x Sep 18, 2026 $220 Call @ $11.00 mid

  • Sell 1x Sep 18, 2026 $230 Call @ $7.40 mid

• Max Gain & Loss:

  • Max Gain: $6.40 per share ($640 per spread)

  • Max Loss: $3.60 per share ($360 per spread)

• Initial Cost/Debit: $3.60 net debit per share ($360 per spread)

🐯🪙 Share your choice and reasoning in the comments — thoughtful views may receive Tiger Coins!

Good allocation isn’t just about investing — it’s also about keeping everyday life organised.

Just like a well-balanced portfolio, the right organisation can make business trips, travel and workouts a little easier. The new Tiger Toiletry Bag features a dual-layer dry & wet separation design with plenty of space to keep your essentials neatly organised, wherever you go.

Redeem the new Tiger Toiletry Bag now in Tiger Coin Mall. https://laohu8.com/J/redeemGift?goodID=100538&type=delivery